These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients. Huang Y; Li Y; Xie F; Guo Q CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638 [TBL] [Abstract][Full Text] [Related]
6. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease. Guo T; Li A; Sun P; He Z; Cai Y; Lan G; Liu L; Li J; Yang J; Zhu Y; Zhao R; Chen X; Shi D; Liu Z; Wang Q; Xu L; Zhou L; Ran P; Wang X; Sun K; Lu J; Han Y Mol Neurodegener; 2024 Jul; 19(1):58. PubMed ID: 39080744 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity. Honig LS; Kang MS; Lee AJ; Reyes-Dumeyer D; Piriz A; Soriano B; Franco Y; Coronado ZD; Recio P; Mejía DR; Medrano M; Lantigua RA; Teich AF; Dage JL; Mayeux R JAMA Netw Open; 2023 Apr; 6(4):e238214. PubMed ID: 37079306 [TBL] [Abstract][Full Text] [Related]
8. Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors. Hajjar I; Yang Z; Okafor M; Liu C; Waligorska T; Goldstein FC; Shaw LM JAMA Netw Open; 2022 Oct; 5(10):e2235068. PubMed ID: 36201209 [TBL] [Abstract][Full Text] [Related]
9. Effects of time of the day at sampling on CSF and plasma levels of Alzheimer' disease biomarkers. Orduña Dolado A; Stomrud E; Ashton NJ; Nilsson J; Quijano-Rubio C; Jethwa A; Brum WS; Brinkmalm Westman A; Zetterberg H; Blennow K; Janelidze S; Hansson O Alzheimers Res Ther; 2024 Jun; 16(1):132. PubMed ID: 38909218 [TBL] [Abstract][Full Text] [Related]
10. The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease. Mohs RC; Beauregard D; Dwyer J; Gaudioso J; Bork J; MaGee-Rodgers T; Key MN; Kerwin DR; Hughes L; Cordell CB; Alzheimers Dement; 2024 Apr; 20(4):2752-2765. PubMed ID: 38415908 [TBL] [Abstract][Full Text] [Related]
11. Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau. Janelidze S; Palmqvist S; Leuzy A; Stomrud E; Verberk IMW; Zetterberg H; Ashton NJ; Pesini P; Sarasa L; Allué JA; Teunissen CE; Dage JL; Blennow K; Mattsson-Carlgren N; Hansson O Alzheimers Dement; 2022 Feb; 18(2):283-293. PubMed ID: 34151519 [TBL] [Abstract][Full Text] [Related]
12. Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds. McCarter SJ; Lesnick TG; Lowe VJ; Rabinstein AA; Przybelski SA; Algeciras-Schimnich A; Ramanan VK; Jack CR; Petersen RC; Knopman DS; Boeve BF; Kantarci K; Vemuri P; Mielke MM; Graff-Radford J J Alzheimers Dis; 2022; 87(4):1537-1547. PubMed ID: 35527558 [TBL] [Abstract][Full Text] [Related]
13. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies. Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW; Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138 [TBL] [Abstract][Full Text] [Related]
14. Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia. Cai Y; Shi D; Lan G; Chen L; Jiang Y; Zhou L; Guo T; Neurology; 2024 Apr; 102(7):e209205. PubMed ID: 38489560 [TBL] [Abstract][Full Text] [Related]